Pembrolizumab (pembro) for previously treated, microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): Final analysis of KEYNOTE-164 Meeting Abstract
| Authors: | Le, D. T.; Diaz, L.; Kim, T. W.; Van Cutsem, E.; Geva, R.; Jäger, D.; Hara, H.; Burge, M.; O'Neil, B.; Kavan, P.; Yoshino, T.; Guimbaud, R.; Taniguchi, H.; Elez, E.; Al-Batran, S. E.; Boland, P.; Cui, Y.; Leconte, P.; Marinello, P.; André, T. |
| Abstract Title: | Pembrolizumab (pembro) for previously treated, microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): Final analysis of KEYNOTE-164 |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S550 |
| Language: | English |
| ACCESSION: | WOS:000700527700410 |
| DOI: | 10.1016/j.annonc.2021.08.953 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 432P -- Source: Wos |
